The 13 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 133.00, with a high estimate of 210.00 and a low estimate of 62.00. The median estimate represents a +156.11% increase from the last price of 51.93.
The current consensus among 14 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.82
Reporting Date May 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.